R1	Has_qualifier Arg1:T1 Arg2:T2	
R2	Has_qualifier Arg1:T5 Arg2:T6	
R3	Subsumes Arg1:T5 Arg2:T7	
R4	Has_qualifier Arg1:T8 Arg2:T9	
R5	Subsumes Arg1:T13 Arg2:T14	
R6	AND Arg1:T12 Arg2:T13	
R7	Subsumes Arg1:T17 Arg2:T18	
R8	Has_value Arg1:T17 Arg2:T19	
R9	Has_value Arg1:T20 Arg2:T21	
*	OR T22 T23 T24 T25
R10	Has_temporal Arg1:T22 Arg2:T26	
T1	Condition 14 32	infectious disease
T2	Qualifier 3 13	underlying
T3	Condition 34 57	chromosomal abnormality
T4	Condition 59 77	metabolic disorder
T5	Condition 102 110	disorder
T6	Qualifier 88 93	brain
T7	Condition 120 138	tuberous sclerosis
T8	Condition 158 183	cytomegalovirus infection
T9	Qualifier 152 157	fetal
T10	Condition 185 199	birth asphyxia
T11	Condition 214 231	major head injury
T12	Condition 235 246	chronic use
T13	Drug 250 287	non-steroidal anti-inflammatory drugs
T14	Drug 290 295	NSAID
T15	Condition 304 316	brain damage
T16	Condition 318 326	Epilepsy
T17	Measurement 337 355	Electro-cardiogram
T18	Measurement 357 360	ECG
T19	Value 328 336	Abnormal
T20	Measurement 376 379	EEG
T21	Value 363 375	Epileptiform
T22	Drug 388 404	psychostimulants
T23	Drug 406 422	anti-depressants
T24	Drug 424 436	neuroleptics
T25	Drug 440 462	anti-convulsive agents
T26	Temporal 463 484	within the past month
T28	Post-eligibility 487 529	Lack of cooperation in the screening phase
